ARTICLE | Distillery Therapeutics
Neurology
April 4, 2017 10:01 PM UTC
Cell culture studies identified prodrugs of the PINK1 agonist kinetin riboside triphosphate that could help treat PD. The prodrugs were kinetin riboside phosphorothioate-based compounds that were clea...
BCIQ Target Profiles